Phosphoric Acid

Phosphoric Acid

SCHEMBL664706

O=P(O)(O)O.O=P(O)(O)O.O=P(O)(O)O.O=P(O)(O)O.[MgH2].[MgH2]

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

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

The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 1/20 0.50
SLC34A1 Q06495 1/20 0.46
FDPS P14324 2/20 0.42
BLM P54132 2/20 0.42
TDP1 Q9NUW8 2/20 0.42
KDM4E B2RXH2 1/20 0.42
MMP2 P08253 1/20 0.42
THRB P10828 1/20 0.42
MAPK1 P28482 1/20 0.42
HSD17B10 Q99714 1/20 0.42
CA4 P22748 1/20 0.38
TYMS P04818 1/20 0.36
LMNA P02545 2/20 0.33
MEN1 O00255 1/20 0.31
HPGD P15428 1/20 0.31
TSHR P16473 1/20 0.31
KMT2A Q03164 1/20 0.31
PGK1 P00558 1/20 0.31
PGK2 P07205 1/20 0.31
ALDH1A1 P00352 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phosphoric Acid SCHEMBL27787828 1.00
Phosphoric Acid SCHEMBL2421461 1.00
Phosphoric Acid SCHEMBL8530391 1.00 CA2 (0.50) CA2SLC34A1FDPSBLMTDP1
Phosphoric Acid SCHEMBL525414 1.00 CA2 (0.50) CA2SLC34A1FDPSBLMTDP1
Phosphoric Acid SCHEMBL8530389 1.00 CA2 (0.50) CA2SLC34A1FDPSBLMTDP1
Phosphoric Acid SCHEMBL524790 1.00 CA2 (0.50) CA2SLC34A1FDPSBLMTDP1
Phosphoric Acid SCHEMBL23409672 1.00 CA2 (0.50) CA2SLC34A1FDPSBLMTDP1
Phosphoric Acid SCHEMBL439315 1.00
Phosphoric Acid SCHEMBL28258 1.00
Phosphoric Acid SCHEMBL396410 1.00 CA2 (0.50) CA2SLC34A1FDPSBLMTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 702 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260123659-A1 NUTRITIONAL FORMULA BUILDING BLOCK NUTRITIONALS LLC (US) 2026-05-07 US claimed
EP-4642246-A2 METHODS AND SYSTEMS FOR INDUCING COALESCENCE OF FUNGAL PROTEINS, AND FUNGAL FOOD PRODUCTS MADE THEREBY The Fynder Group, Inc. (US) 2025-11-05 EP claimed
US-12302934-B2 Nutritional formula BUILDING BLOCK NUTRITIONALS, LLC (US) 2025-05-20 US claimed
EP-4521957-A1 A BAG SYSTEM CONTAINING A NUTRIENT COMPOSITION COMPRISING WHOLE FOOD SOLE SOURCE MEAL Kate Farms Inc. (US) 2025-03-19 EP claimed
EP-4504354-A1 MAGNESIUM CHLORIDE FIRE RETARDANT COMPOSITIONS Perimeter Solutions LP (US) 2025-02-12 EP claimed
US-20240408428-A1 MAGNESIUM CHLORIDE FIRE RETARDANT COMPOSITIONS U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS NOTES COLLATERAL AGENT 2024-12-12 US claimed
EP-3728136-B1 CHEMICAL PROCESSING OF STRUVITE EASYMINING SWEDEN AB (SE) 2024-11-20 EP claimed
US-12139442-B2 Biochar product, its use in fertilizers, and methods of making the biochar IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2024-11-12 US claimed
EP-4427601-A1 PROCESS FOR TEXTURING A PLANT-BASED PROTEIN COMPOSITION COMPRISING WET EXTRUSION, AN ACID AND/OR A BASE Les Nouveaux Fermiers (FR) 2024-09-11 EP claimed
EP-4427600-A1 PROCESS FOR TEXTURING A PLANT-BASED PROTEIN COMPOSITION COMPRISING WET EXTRUSION, AN ACID AND/OR A BASE Les Nouveaux Fermiers (FR) 2024-09-11 EP claimed
EP-0345032-B1 Method and composition for laser-marking DAINIPPON INK & CHEMICALS (JP) 1996-09-11 EP claimed
EP-0648421-A2 Novel leavening composition MONSANTO COMPANY (US) 1995-04-19 EP claimed
US-5405636-A A baking powder mixtures comprising dimagnesium phosphate trihydrate, amorphous dimagnesium phosphate and a small amount of magnesium pyrophosphate; heat activated for baking goods MONSANTO COMPANY (US) 1995-04-11 US claimed
US-5035983-A Lead compound, heat resistance, discoloration inhibition DAINIPPON INK AND CHEMICALS, INC. (JP) 1991-07-30 US claimed
EP-0345032-A2 Method and composition for laser-marking DAINIPPON INK AND CHEMICALS, INC. (JP) 1989-12-06 EP claimed
US-4828823-A STABILIZATION STAUFFER CHEMICAL COMPANY (US) 1989-05-09 US claimed
EP-0240880-A2 Dicalcium phosphate dihydrate for fluoride dentifrice compositions STAUFFER CHEMICAL COMPANY (US) 1987-10-14 EP claimed
US-4472365-A Dicalcium phosphate dihydrate having improved monofluorophosphate compatibility and process for the preparation thereof STAUFFER CHEMICAL COMPANY (US) 1984-09-18 US claimed
EP-0024509-B1 PROCESS FOR PRODUCING MINERAL MIXED PROVENDERS HOECHST AKTIENGESELLSCHAFT (DE) 1983-05-25 EP claimed
US-4312843-A TOOTHPASTES STAUFFER CHEMICAL COMPANY (US) 1982-01-26 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260123659-A1 NUTRITIONAL FORMULA FABP2, LPO, LPL CA2 2719/4885SLC34A1 1466/4885FDPS 2200/4885
US-12302934-B2 Nutritional formula FABP2, ALOX5, LPO CA2 3114/4885SLC34A1 1872/4885FDPS 1603/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.